X Bioscience PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1.57	9.19	26.75	16.16	28.01
Short-Term Investments	3.09	38.77	-	-	-
Cash & Short-Term Investments	4.66	47.96	26.75	16.16	28.01
Cash Growth	-90.28%	79.30%	65.57%	-42.33%	-35.48%
Accounts Receivable	0.25	27.65	0.59	3.71	5.07
Other Receivables	10.86	16.33	28.56	14.12	18.19
Receivables	11.11	43.98	29.15	17.83	23.26
Inventory	2.22	11.87	6.76	13.09	35.12
Prepaid Expenses	0.7	3.19	1.43	1.54	3.28
Other Current Assets	283.03	0.17	7.09	6.51	9.8
Total Current Assets	301.72	107.17	71.19	55.12	99.47
Property, Plant & Equipment	98.72	596.29	213.87	173.56	294.62
Long-Term Investments	-	27.25	-	-	-
Goodwill	123.39	335.35	246.18	267.44	516.1
Other Intangible Assets	70.86	319.23	146.54	150.05	364.85
Long-Term Deferred Tax Assets	-	0.13	-	-	-
Other Long-Term Assets	14.63	28.93	61.6	53.92	45.55
Total Assets	609.31	1,414	739.39	700.09	1,321
Accounts Payable	38.44	46.65	28.22	29.54	71.01
Accrued Expenses	45.45	39.3	38.33	25.24	17.5
Short-Term Debt	183.21	251.86	293.24	340.34	301.54
Current Portion of Long-Term Debt	2.93	3.05	3.05	3.21	3.14
Current Portion of Leases	14.64	22.16	26.64	27.23	36.39
Current Unearned Revenue	0.37	6.12	1.68	0.38	0.3
Other Current Liabilities	40.77	64.14	35.02	31.17	28.05
Total Current Liabilities	325.81	433.26	426.2	457.12	457.94
Long-Term Debt	3.71	5.93	8.29	10.68	13.2
Long-Term Leases	35.86	71.57	83.81	91.51	114.78
Pension & Post-Retirement Benefits	6.59	5.4	3.25	2.3	6.95
Long-Term Deferred Tax Liabilities	10.61	64.88	27.88	29.01	34.65
Other Long-Term Liabilities	3.53	5.88	7.15	6.94	19.66
Total Liabilities	386.11	586.93	556.58	597.55	647.19
Common Stock	7,352	1,944	1,031	813.91	813.91
Retained Earnings	-1,845	-1,376	-1,116	-968.77	-397.91
Comprehensive Income & Other	-5,290	-53.66	268.5	257.4	257.4
Total Common Equity	216.62	513.52	182.8	102.54	673.4
Minority Interest	6.58	313.91	0	0	0
Shareholders' Equity	223.2	827.43	182.81	102.54	673.41
Total Liabilities & Equity	609.31	1,414	739.39	700.09	1,321
Total Debt	240.36	354.56	415.04	472.98	469.05
Net Cash (Debt)	-235.69	-306.6	-388.29	-456.82	-441.04
Net Cash Per Share	-0.59	-1.67	-3.10	-3.93	-3.79
Filing Date Shares Outstanding	1,050	277.66	147.23	116.27	116.27
Total Common Shares Outstanding	1,050	277.66	147.23	116.27	116.27
Working Capital	-24.09	-326.09	-355.01	-402	-358.47
Book Value Per Share	0.21	1.85	1.24	0.88	5.79
Tangible Book Value	22.37	-141.06	-209.92	-314.95	-207.55
Tangible Book Value Per Share	0.02	-0.51	-1.43	-2.71	-1.79
Land	-	126	-	-	-
Buildings	63.21	109.74	-	-	-
Machinery	30.9	354.01	70.33	72.44	123.46
Construction In Progress	2.59	8.56	16.51	2.3	11.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.